Navigation Links
CRESTOR(R) Reduced CV Risk in Patients Achieving Low LDL and hsCRP Targets in New JUPITER Analysis
Date:3/29/2009

New England Journal of Medicine, evaluated the impact of rosuvastatin 20mg on reducing major cardiovascular (CV) events (combined risk of myocardial infarction, stroke, arterial revascularization, hospitalization for unstable angina, or death from CV causes).

JUPITER was a long-term, randomized, double-blind, placebo-controlled, large-scale study of 17,802 patients designed to determine if rosuvastatin 20 mg decreases the risk of heart attack, stroke and other major cardiovascular events in patients with low to normal LDL-C but at increased cardiovascular risk as identified by age and elevated high-sensitivity C-reactive protein (hsCRP). The majority of patients had at least one other risk factor including hypertension, low HDL-C, family history of premature coronary heart disease (CHD) or smoking. hsCRP is a recognized marker of inflammation which is associated with an increased risk of atherosclerotic cardiovascular events.

JUPITER is a part of AstraZeneca's extensive GALAXY clinical trials program, designed to address important unanswered questions in statin research. Currently, more than 69,000 patients have been recruited from 55 countries worldwide to participate in the GALAXY Program.

AstraZeneca has previously announced that it expects to file a regulatory submission including the JUPITER data in the first half of 2009 and if approved will begin promotional activities within the approved labeling.

ABOUT CRESTOR (ROSUVASTATIN CALCIUM):

Studies have previously shown that CRESTOR significantly lowered LDL-C, had a significant effect on raising HDL-C and slowed the progression of atherosclerosis, the build-up of plaque in the arteries.

CRESTOR has now received regulatory approval in over 90 countries. More than 13 million patients have been prescribed CRESTOR worldwide. Data from clinical trials and real world use shows that the safety profile for CRESTOR
'/>"/>

SOURCE AstraZeneca
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
2. New Analysis of METEOR Study Demonstrate Effects of AstraZenecas CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease
3. Phase III Study of Abbotts Investigational TriLipix(TM) in Combination With AstraZenecas CRESTOR(R) Meets Primary Endpoints on Key Lipids
4. Abbotts Phase III Sub-Group Analysis Shows Investigational TriLipix(TM) in Combination with CRESTOR(R) Improves Key Lipids in Patients with Mixed Dyslipidemia and Type 2 Diabetes
5. CRESTOR(R) Reduced Risk of Blood Clots in the Veins
6. New Data Suggest Cymbalta(R) Reduced Pain in Fibromyalgia Patients With and Without Depression
7. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
8. Risedronate Reduced Risk of Fracture Among Osteoporotic Postmenopausal Women with History of Hip Fracture
9. ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes
10. INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients
11. New Data Published in Neurology Show Once-Daily Lamictal XR Significantly Reduced Partial Seizures in Patients with Epilepsy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... , June 19, 2013 /PRNewswire/ ... has recently added DrugPatentWatch to its ... http://www.bharatbook.com/drugpatentwatch-tour.pdf )      (Logo: ... comprehensive information on pharmaceutical, drug patents ... supports the critical business functions of ...
(Date:6/19/2013)... -- DST Health Solutions, LLC (DSTHS), a leading provider ... delivery systems, and health care providers, has announced that ... has jumped significantly. A customizable solution ... medical prescription drug claims, MDMS allows health ... claims processes. As specialty drug demand grows due to ...
(Date:6/19/2013)... Calif. , June 19, 2013   ... today announces a licensing agreement granting Suzhou Ribo ... and manufacture siRNA therapeutics in China ...  Ribo will formulate proprietary siRNA molecules in combination ... designed to address human diseases with high unmet ...
Breaking Medicine Technology:Drug Patent Watch 2Drug Patent Watch 3Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 2Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 2Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 4
... medical device company focused on developing unique modular spinal fusion ... a 97% sales increase for 2010 versus 2009, with a ... the prior-year period.  The company also reports an average growth ... RSB Spine Chief Executive Officer John A. Redmond said: "It ...
... The Alpha-1 Foundation announced today that it has awarded ... to our understanding of the causes and mechanisms that ... investigate how cigarette smoke promotes the onset of emphysema ... and how the alpha(1)-proteinase inhibitor (A1PI) protein protects the ...
Cached Medicine Technology:Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc. 2Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc. 3Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc. 4
(Date:6/19/2013)... 19, 2013 HASCO Medical, Inc. ... its intent to purchase privately held Auto Mobility ... in wheelchair accessible vehicle sales, service and rentals ... Sales, Inc compliments and expands HASCO's strategy of ... mobility dealers . The acquisition is subject to ...
(Date:6/19/2013)... 2013 Brain not working? Functional medicine ... why such seemingly minor brain problems as brain fog, ... red flags. They indicate the brain may be degenerating—or ... Alzheimer’s, Parkinson’s, stroke, and other neurological diseases. Why ... by Elephant Press is now available online at ...
(Date:6/19/2013)... City, Utah (PRWEB) June 19, 2013 ... Wisconsin Health Insurance Exchange . Zane Benefits, which ... health benefits, is the leader in defined contribution ... According to Zane Benefits’ website, as part of the ... and small businesses will become available through new state ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 According to a ... Surviving Weekend Sunburn,” it is not uncommon for a person ... summer months. A person is likely to forget to reapply ... which is both dry and itchy. When this occurs, it ... to goo.gl/gDyjP). , “Most people do not realize that milk ...
(Date:6/19/2013)... (June 19, 2013) In what is believed to ... most common form of hereditary dystonia a movement ... in deep brain stimulation report good success rates and ... the Movement Disorders Program at Cedars-Sinai Medical Center,s Department ... the Division of Neurosurgery at Beth Israel Deaconess Medical ...
Breaking Medicine News(10 mins):Health News:HASCO Medical, Inc. to Acquire Auto Mobility Sales, Inc. 2Health News:Brain Not Working? Minor Symptoms Now Could Mean MS, Alzheimer's, or Parkinson's Later 2Health News:Brain Not Working? Minor Symptoms Now Could Mean MS, Alzheimer's, or Parkinson's Later 3Health News:Zane Benefits Publishes New Information on the Wisconsin Health Insurance Exchange 2Health News:Zane Benefits Publishes New Information on the Wisconsin Health Insurance Exchange 3Health News:Skin Care – How to treat Sunburn 2Health News:Long-term study reports deep brain stimulation effective for most common hereditary dystonia 2
... January 7, Discovery Health Presents Five Nights of Active, Viewing ... ... FIT TO LIVE -, SILVER SPRING, Md., Dec. 11 ... annual,weight loss and general wellness campaign-launches with a four-part,television event following ...
... American Red Cross Provides Tips on What to Do ... Dec. 11 American Red Cross,chapters throughout the Midwest ... outages and a frozen landscape, despite several,chapter offices being ... and employees are working from home or using partnerships ...
... Dec. 11 AIDS Healthcare,Foundation (AHF) today blasted ... Huckabee, for his stubbornness and,recent failure to apologize ... campaign in which he called for people living ... At the time, Huckabee,told Associated Press in response ...
... Consumers with Unaffordable Mandate, SANTA MONICA, Calif., Dec. ... as 14% have led a state panel,to propose a ... The vote,came less than a month before every citizen ... penalties that increase monthly, and as,California politicians and labor ...
... Party to Commit to Creating,Evidence Based National HIV/AIDS ... released a,statement today calling on Presidential Candidate Mike ... the policies he would undertake as,President conform to ... HIV. "Governor Huckabee,s 1992 statement calling for the,quarantine ...
... Nature, Brandeis University Howard Hughes Medical Investigator Dr. Dorothee ... secret lives of enzymes, the ubiquitous proteins that catalyze ... sophisticated technologies to capture a key enzyme changing shape ... that these proteins are not the wallflowers of the ...
Cached Medicine News:Health News:Overweight Twins Battle the Bulge and Gain A New Lease on Life in National Body Challenge: Twins Edition on Discovery Health 2Health News:Overweight Twins Battle the Bulge and Gain A New Lease on Life in National Body Challenge: Twins Edition on Discovery Health 3Health News:Overweight Twins Battle the Bulge and Gain A New Lease on Life in National Body Challenge: Twins Edition on Discovery Health 4Health News:Darkness and Cold Prevail in the Midwest 2Health News:Darkness and Cold Prevail in the Midwest 3Health News:Darkness and Cold Prevail in the Midwest 4Health News:Huckabee's Defense of Earlier, Alarmist AIDS Stance Shows Unsuitability for Presidency, Says AHF 2Health News:Double-Digit Rate Increases Expected Under Mass. Mandatory Health Law; 5% Cap on Rate Hikes Proposed 2Health News:AIDS Action Calls on Huckabee to Follow HIV/AIDS Science 2Health News:Caught in the act: The dynamic dance of enzymes 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: